For the Press
Members of the press are welcome to freely use the materials linked below.
If you have any questions regarding any of these materials, please contact us by using the Inquiry Form linked below.
- Nov. 22, 2023 Sumitomo Pharma Announces the Approval of XENLETA (lefamulin acetate) for the Treatment of Community-Acquired Pneumonia in China
- Nov. 20, 2023 Sumitomo Pharma and ORIX Eco Services to Collaborate on Recycling Blister Packaging Waste at Suzuka Plant
- Nov. 10, 2023 Sumitomo Pharma Receives SBTi (Science Based Targets initiative) Approval
- Nov. 06, 2023 Posted Video of Conference on Q2 FY2023 Financial Results [Webcast]
- Nov. 06, 2023 Sumitomo Pharma America to Present Preliminary Clinical Data Evaluating Investigational Oncology Agents TP-3654 and DSP-5336 at the American Society of Hematology Annual Meeting（169KB / PDF）
Inquiries from the Press
You will be taken to the page for members of the press.
Information concerning pharmaceuticals and medical devices (including those that are under development) included in our Press Releases are included solely for the purpose of facilitating corporate disclosure, and not for the purpose of promoting or advertising any specific product, or giving any medical advice or opinion.
- The latest Integrated Report can be viewed/downloaded from here.
Reports from previous years can be found here.
Mid-term Business Plan 2027
Mid-term Business Plan 2027 and presentation material can be viewed/downloaded from here.
Regenerative Medicine / Cell Therapy
- The materials from the presentation given during the opening tour of Sumitomo Manufacturing Plant for Regenerative Medicine & Cell Therapy “SMaRT” on March 1, 2018 can be viewed from here.
- Related Press Release
- The dedicated Frontier Business website can be found here.
- The materials from and video recording of the Frontier Business Meeting - FBO Showcase - held on September 8, 2021 can be viewed/downloaded from here.
Pictures of our Sites
- Pictures of our various Sites can be downloaded from here.